Amgen's cholesterol drug Repatha has been given the green light ... The drug is given in the form of a subcutaneous injection, either 140 mg every two weeks or 420mg once a month.

Amgen’s Repatha (evolocumab ... and a rarer homozygous (HoFH) form of the condition, in addition to those with cardiovascular disease. Praluent is approved in cardiovascular disease and HeFH ...

Attorney Jeffrey Lamken said at arguments in March that Amgen’s patents are for all antibodies that would bind to PCSK9, including those used in Repatha. Although a federal jury in Delaware sided with ...

Amgen’s key medicines, like Evenity and Repatha, newer medicines like Tavneos and Tezspire and rare disease drugs, mostly products added from the Horizon acquisition, are driving sales.

Quantbot Technologies LP boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 219.5% during the fourth ...